Biocydex Competitors and Similar CompaniesClear all
Rigel Pharmaceuticals's competitors and similar companies include Fortrea and Bryleos.
 Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. |  Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). | ||
Founding Date | Founding Date 1996 | Founding Date 2023 | Founding Date 2021 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations South San Francisco, US HQ | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more | Locations Johnson City, US HQ |
Employees | Employees 1633% increase | Employees 19,000 | Employees 7 |
Valuation ($) | Valuation ($) 256 m | Valuation ($) 1.6 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $294.3m (FY, 2025) | Revenue (est.) $2.7b (FY, 2025) | Revenue (est.) N/A |
Net income | Net income $367m (FY, 2025) | Net income ($986.2m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 130m | Total funding raised N/A | Total funding raised $ 5m |
For sources of this data, please see the company profile
View Company Profiles
Fortrea
HQ
Durham, US
Employees
19,000
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
View company
Bryleos
HQ
Johnson City, US
Employees
7
Bryleos (also known as BioNADrx Holdings) is a clinical stage therapeutics company.
View company